Catatonia in a 14 year-old girl: Treatment with clorazepam and carbamazepine, a 10-year follow-up;Catatonie chez une adolescente de 14 ans: Traitement par clorazépam et carbamazépine et évolution à dix ans

Encephale

Volumn 36, Issue 1, 2010, Pages 46-53

  Askenazy, F ^a   Dor, E ^a   Benoit, M ^a   Dupuis, G ^a   Serret, S ^a   Myquel, M ^a   Seddiki, Y ^a  

^a Fondation Lenval Hopital pour Enfants   (France)

Author keywords

Adolescent; Benzodiazepines; Carmabazepine; Catatonia

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; HALOPERIDOL; LOXAPINE;

ADOLESCENT; AGITATION; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CATALEPSY; CATATONIA; CLINICAL FEATURE; COGNITIVE DEFECT; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; IMPULSIVENESS; INTELLIGENCE QUOTIENT; INTENSIVE CARE UNIT; LANGUAGE DEVELOPMENT; LANGUAGE DISABILITY; LONG TERM SURVIVAL; NEUROLEPTIC MALIGNANT SYNDROME; PARANOIA; PARENTERAL NUTRITION; SELF CARE; SPECIAL EDUCATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE INCONTINENCE; VISUAL HALLUCINATION;

EID: 84866727319     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2009.01.006     Document Type: Article

References (43)

1. Américan Psychiatric Association. Diagnostic and Statistical Manual of mental disorders, 4 th edition (DSM IV-R).Washington DC: American Psychiatric Association, 1994.
2. Bachmann CJ, Nicksh B, Theissen FM, et al. Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in adolescent (letter). J Clinical Psychopharmacol 2007;27:710-1.
3. Bond TC. Recognition of acute delirious mania. Arch Gen Psychiatry 1980;37:553-4.
4. Bush G, Fink M, Petrides G, et al. Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-36.
5. Caroff SN, Mann SC, Keck Jr PE, et al. Residual catatonic state following neuroleptic malignant syndrome. J Clin Psychopharmacol 2000;2:257-9.
6. Carroll BT, Taylor RE. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome (letter). J Clin Psychopharmacol 1997;17:235-6.
7. Cohen D, Flament M, Dubos PF, et al. Case series: catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 1999;38:1040-6.
8. Cohen D, Flament M, Taieb O, et al. Electroconvulsive therapy in adolescence. Eur Child Adolesc Psychiatry 2000;9: 1-6.
9. Cohen D, Nicolas JD, Flament MF, et al. Clinical relevance of chronic catatonic schizophrenia in children and adolescents: evidence from a prospective naturalistic study. Schizophrenia Res 2005;76:301-8.
10. Fink M. Catatonia in DMS-IV. Biol Psychiatry 1994;36:431-3.
11. Fink M, Carlson GA. ECT and prepubertal children (Letter). J Am Acad Child Adolesc Psychiatry 1995;34:1256-7.
12. Fink M. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996;39:1-4.
13. Fink M. Delirious mania. Bipolar Disord 1999;1:54-60.
14. Fink M. Treating Neuroleptic Malignant Syndrome as catatonia. J Clin Psychopharmacol 2001;21:121-2.
15. Fricchione GL. Neuroleptic catatonia and its relationship to psychogénic catatonia. Biol Psychiatry 1985;20:304-13.
16. Fricchione GL, Cassem NH, Hooberman D, et al. Intraveinous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983;3:338-42.
17. Fricchione GL, Kaufman LD, Gruber BL, et al. Electroconvulsivo therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med 1990;88:442-3.
18. Graham P. Indication of ECT in child psychiatry. J Am Acad Child Adolesc Psychiatry 1995;35:1420.
19. Hanft A, Eggleston CF, Bourgeois JA. Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child. Adolesc Psychopharmacol 2004;14:481-7.
20. Hynes AFM, Vickar EL. Case study: Neuroleptic Malignant Syndrome without pyrexia. J Am Acad Adolesc Psychiatry 1996;35:959-62.
21. Johnson J. Stupor: a review of 25 cases. Acta Psychiatr Scan 1984;70:370-7.
22. Kahlbaum KL. Die katatonie oder das spannungsirresein. Berlin: verlag August Hirhwald; 1874.
23. Kritzinger PR, Jordaan GP, et al. An open prospective series with Carbamazépine. Int J Neuropsychopharmacol 2001;4:251-7.
24. Lahutte B, Cornic F, Bonnot O, et al. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1393-8.
25. Meltzer HY, Cola PA, Parsa M. Marked elevations of serum creatine kinase activity associated with antipsychoic drug treatment. Neuropsychopharmacoly 1996;15:395-405.
26. Natesan S, Reckless GE, Nobrega JN, et al. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology 2006;31:1854-63. Epub 2005 Nov 30.
27. Organisation mondiale de la santé. Classification Internationale des Maladies (10e Édition). Paris: Masson;1994.
28. Pommepuy N, Januel D. La catatonie : résurgence d'un concept; une revue de la littérature internationale. L'Encéphale 2002;28:481-92.
29. Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003;60:681-90.
30. Rankel HW, Rankel LE. Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988;145:361-2.
31. Revuelta E, Bordet R, Piquet T, et al. Catatonie aiguë et syndrome malin des neuroleptiques : un cas de psychose infantile. Encéphale 1994;20:351-4.
32. Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry 1997;154:595-602.
33. Shiloh R, Schwartz B, Weizman A, et al. Catatonia as an unusual presentation of posttraumatic stress disorder. Psychopathology 1995;28:85-90.
34. Strawn JR. Aripiprazole and the neuroleptic malignant syndrome. Schizophr Res 2006;85:298-9. Epub 2006 May 5.
35. Takaoka K, Takata T. Catatonia in chilhood and adolescence. Psychiatry and Clinical Neurosciences 2003;57: 129-37.
36. Taylor MA, Fink M. Catatonia in Psychiatric Classification: A Home of its OwAm. J Psychiatry 2003;160:1233-41.
37. Thakur A, Jagadsen K, Dutta S, et al. Incidence of catatonia in children and adolescents in a pediatric psychiatric clinic. Austr New Zeland J Psychiatry 2003;37:200-3.
38. Ungvari GS, Leung CM, Lee TS. Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry 1994;27:242-5.
39. Wachtel LE, Kahng S, Dhossche DM, et al. ECT for catatonia. Am J Psychiatry 2008;65:329-33.
40. White DAC, Robins AH. Catatonia: Harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991;158:419-21.
41. White DAC. Catatonia and the neuroleptic malignant syndrome a single entity? Br J Psychiatry 1992;161:558-60.
42. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry 2000;176:357-62.
43. Woodbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic Malignant Syndrome. J Am Acad Child Adolesc Psychiatry 1992;31:1161-4.